Want to see AU:RGT full AI Analyst Report?
Argent Biopharma (RGT) Share Forecast & Price Target
RGT Analyst Ratings
There are no analyst ratings in the last 3 months.
RGT Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts​
| Analyst Profile | Expert Firm | Price Target | Position | Upside / Downside | Action | Date | Follow | Article |
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | TipRanks - PerPlexity | AUD 0.03→AUD 0.02 | sell | -4.00%Downside | Downgraded | 10/31/26 | ||
| Google Drug Manufacturers - Specialty and Generic | TipRanks - Google | AUD 0.03→AUD 0.02 | sell | -8.00%Downside | Reiterated | 10/31/26 | ||
| Anthropic Drug Manufacturers - Specialty and Generic | TipRanks - Anthropic | AUD 0.03→AUD 0.02 | sell | -4.00%Downside | Reiterated | 10/31/26 | ||
| OpenAI - Gpt-5.6Sol | TipRanks - OpenAI | AUD 0.03→AUD 0.02 | sell | -4.00%Downside | Reiterated | 10/31/26 | ||
| DeepSeek - V4Pro | TipRanks - DeepSeek | AUD 0.03→AUD 0.02 | sell | -8.00%Downside | Downgraded | 10/31/26 | ||
| xAI - Grok-4.3 | TipRanks - xAI | AUD 0.03→AUD 0.02 | sell | -4.00%Downside | Reiterated | 10/31/26 |
| Analyst Profile | Date | Price Target | Position | Upside / Downside | Action | Follow | Article | Expert Firm |
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | 10/31/26 | AUD 0.03→AUD 0.02 | sell | -4.00%Downside | Downgraded | TipRanks - PerPlexity | ||
| Google Drug Manufacturers - Specialty and Generic | 10/31/26 | AUD 0.03→AUD 0.02 | sell | -8.00%Downside | Reiterated | TipRanks - Google | ||
| Anthropic Drug Manufacturers - Specialty and Generic | 10/31/26 | AUD 0.03→AUD 0.02 | sell | -4.00%Downside | Reiterated | TipRanks - Anthropic | ||
| OpenAI - Gpt-5.6Sol | 10/31/26 | AUD 0.03→AUD 0.02 | sell | -4.00%Downside | Reiterated | TipRanks - OpenAI | ||
| DeepSeek - V4Pro | 10/31/26 | AUD 0.03→AUD 0.02 | sell | -8.00%Downside | Downgraded | TipRanks - DeepSeek | ||
| xAI - Grok-4.3 | 10/31/26 | AUD 0.03→AUD 0.02 | sell | -4.00%Downside | Reiterated | TipRanks - xAI |
Best Analysts Covering Argent Biopharma
Copying OpenAI Drug Manufacturers - Specialty and Generic's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +30.20% per trade.
Copying OpenAI Drug Manufacturers - Specialty and Generic's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +30.20% per trade.
Copying OpenAI Drug Manufacturers - Specialty and Generic's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +30.20% per trade.
RGT Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, RGT has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. RGT average Analyst price target in the past 3 months is ―.
RGT Financial Forecast
RGT Sales Forecast
Next quarter’s sales forecast for RGT is AUD 0 with a range of ― to ―. The previous quarter’s sales results were AUD 171.50K. RGT beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year RGT has Performed in-line its overall industry.